Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
abrdn Healthcare Investors 9-Day RSI Related Terms
HQH vs DSL, NMZ, JFR: 9-Day RSI Comparison
For the Asset Management subindustry, abrdn Healthcare Investors's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
abrdn Healthcare Investors 9-Day RSI vs Asset Management Industry
For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where abrdn Healthcare Investors's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Healthcare Investors (HQH) has a 9-Day RSI of 40.88 as of Jul. 20, 2026. According to the industry distribution chart, abrdn Healthcare Investors ranks #552 out of 1695 companies in the Asset Management industry, placing it in the top 32.6%.
Is abrdn Healthcare Investors' 9-Day RSI too high?
abrdn Healthcare Investors' current 9-Day RSI is 40.88. The Asset Management industry median 9-Day RSI is 47.13. abrdn Healthcare Investors' value of 40.88 is 13.3% below this industry median. Based on the distribution chart, abrdn Healthcare Investors ranks #552 out of 1695 companies in the Asset Management industry, which is above the industry midpoint. Overall, abrdn Healthcare Investors has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' 9-Day RSI compare to DSL and NMZ?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #552 out of 1695 companies for 9-Day RSI. This puts abrdn Healthcare Investors in the upper half of its industry. The industry median 9-Day RSI is 47.13. abrdn Healthcare Investors' value of 40.88 is 13.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for an Asset Management company?
The median 9-Day RSI among Asset Management companies is 47.13, based on 1,695 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. abrdn Healthcare Investors's current 9-Day RSI of 40.88 is 13.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Asset Management industry, the median 9-Day RSI is 47.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. abrdn Healthcare Investors's current 9-Day RSI is 40.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $20.91 — trading 58.4% below its estimated fair value. The current 9-Day RSI is 40.88 and 13.3% below the Asset Management industry median of 47.13. abrdn Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current 9-Day RSI is 40.88 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is abrdn Healthcare Investors (HQH) Overvalued in 2026?
Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued.
The current stock price of $20.91 is trading 58.4% below its estimated GF Value™ of $50.26.
GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.
Key valuation signals for HQH:
9-Day RSI: 40.88
GF Value™: $50.26 vs. price of $20.91 (58.4% below fair value)
Industry Position: 13.3% below the Asset Management median (#552 of 1695)
No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
49GF Score
Get the complete analysis for HQH
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HQH has been successfully added to your 
